POTTER v. VALEANT PHARMACEUTICALS INTERNATIONAL, INC.

District Court, D. New Jersey·Decided September 21, 2021·No. 3:15-cv-07658·Unknown

Opinion

NOT FOR PUBLICATION UNITED STATES DISTRICT COURT DISTRICT OF NEW JERSEY

IN RE VALEANT PHARMACEUTICALS Civil Action No. 15-7658 (MAS) (LHG) INTERNATIONAL, INC. SECURITIES LITIGATION MEMORANDUM OPINION

SHIPP, District Judge This matter comes before the Court on PricewaterhouseCoopers LLP’s (“PwC”) Objection to the Special Master’s Report and Recommendation! on its Motion for Judgment on the Pleadings (the “Objection”). (ECF No. 573.) Plaintiff City of Tucson, together with and on behalf of the Tucson Supplemental Retirement System (“Tucson”), and the Direct Action Plaintiffs opposed (ECF Nos, 588, 589), and PwC replied (ECF No. 591). The Court has carefully considered the parties’ submissions and decides the matter without oral argument under Local Civil Rule 78.1. For the reasons below, the Court overrules PwC’s Objection. 1. BACKGROUND The parties are familiar with the factual and procedural history of this matter and therefore the Court recites only those facts relevant to the instant Objection. See In re Valeant Pharms. Int'l, Sec. Litig. (“In re Valeant”), No. 15-7658, 2017 WL 1658822 (D.N.J. Apr. 28, 2017). After “further analy[zing]” the two pages of securities transactions listed in Tucson’s June 2016 Certification (the “Certification”), PwC moves to dismiss Tucson’s claim under Section 11 of the Securities Act, 15 U.S.C. § 77k (‘Section 11”) again—over two years after it unsuccessfully

Though styled as an Order and Opinion, there is no dispute that the Special Master’s decision is a Report and Recommendation. (See Order *4, ECF No. 484.)

moved to dismiss the same claim. (Def.’s Moving Br. | n.1, ECF No. 574-1); In re Valeant, 2017 WL 1658822, at *13—-14. This second attempt fares no better. A. Tucson’s Section 11 Claim Tucson alleges that it purchased stock of Valeant Pharmaceuticals International, Inc. “Valeant”) at the company’s March 2015 public offering, that the offering materials contained false and misleading statements made by PwC, and that it “was damaged thereby.” (Am. Consolidated Compl. (“AC”) 99 32, 718-19, ECF No. 574-2.) Pointing to the Certification, Tucson asserts that it purchased 300 shares of Valeant stock at the inflated share price of $199 and then—after revelations of the alleged misconduct caused Valeant’s stock price to drop—sold its stock at share prices ranging between $35 and $158. (Pls.’ Moving Br. 2 (citing Pls.’ Cert. *2—3, ECF No. 80-3), ECF No. 574-2.) B. Procedural History Tucson’s Certification is attached to the Consolidated Complaint that was filed in June 2016. (See ECF Nos. 80, 80-1.) In that complaint, Tucson brought a claim against PwC under Section 11 of the Securities Act of 1933. (Consolidated Compl., 669-712, ECF No. 80.) PwC moved to dismiss Tucson’s Section 11 claim in September 2016 (ECF No. 165), and the Court denied that motion in April 2017 (ECF No. 217). Tucson’s Section 11 claim ts currently set forth in Count Nine of the Amended Consolidated Complaint, which was filed in September 2018. (AC J§ 701-44.) This matter was referred to the Special Master in September 2019. (See generally Order, ECF No. 484.) PwC filed the underlying Motion for Judgment on the Pleadings in December 2019, and the Motion was fully

* Tucson held 11,900 shares of Valeant stock at the time of the offering. (Pls.’ Cert. *3.) (All numbers preceded by an asterisk refer to the page number in the ECF header.)

briefed in March 2020. (See ECF No. 574.) On May 21, 2020, the Special Master issued his report, recommending that the Court deny PwC’s Motion. This Objection followed. I. LEGAL STANDARDS The Court reviews objections to the Special Master’s findings of fact and conclusions of law de novo. (Order *4); Fed. R. Civ. P. 53(£)(3)-(4). Federal Rule of Civil Procedure 12(c)’ provides that “[a]fter the pleadings are closed—but early enough not to delay trial—a party may move for judgment on the pleadings.” Fed. R. Civ. P. 12(c). “The standards governing Rule 12(c) motions are the same ones that govern motions to dismiss under Rule 12(b)(6).” Allah v. Hayman, 442 F. App’x 632, 635 (3d Cir. 2011) (citing Spruill vy. Gillis, 372. F.3d 218, 223 n.2 (3d Cir. 2004)). “Like Rule 12(b)(6), Rule 12(c) requires the Court [to] ‘accept the allegations in the complaint as true[] and draw all reasonable factual inferences in favor of the plaintiff.’” Syresort Inc. v. Sequential Software, Inc., 50 F. Supp. 2d 318, 324 (D.N.J. 1999) (quoting Turbe v. Gov't of V.I., 938 F.2d 427, 428 (3d Cir. 1991)). A court may grant a Rule 12(c) motion only if the movant “clearly establishes that no material issue of fact remains to be resolved and that [the movant] is entitled to judgment as a matter of law.” Rosenau v. Unifund Corp., 539 F.3d 218, 221 (3d Cir. 2008) (quoting Jablonski v. Pan Am. World Airways, Inc,, 863 F.2d 289, 290 (3d Cir. 1988)). Ill. DISCUSSION A. Parties’ Positions PwC argues that Tucson “has no damages|,| and thus no viable Section 11 claim,” because Tucson sold its Valeant stock for a profit. (Def.’s Moving Br. 1.) Tucson reaches that conclusion by purportedly using the matching methodology “endorsed by the overwhelming weight of

3 All references to a “Rule” hereinafter refer to the Federal Rules of Civil Procedure.

authority’—the last-in, first-out method (“LIFO”). (Id. at 1, 8.)* Under LIFO, “stocks acquired most recently are assumed to have been the first sold.” Bo Young Cha v. Kinross Gold Corp., No. 12-1203, 2012 WL 2025850, at *3 (S.D.N.Y. May 31, 2012). Applying LIFO, PwC asserts that shortly after purchasing the 300 shares of Valeant stock, Tucson sold those shares at prices above the $199 share price and profited over $12,000. (Def.’s Moving Br. 8-9.) Thus, PwC argues, Tucson “did not suffer damages, a required element of its claim.” (/d. at 1.) In opposition, Tucson asserts that damages are an affirmative defense to—not an essential element of—a Section 11 claim. (Pls.? Opp’n Br. 2.) Tucson also asserts that, regardless, it adequately pled damages and that it would be improper to apply any specific matching methodology at this stage of litigation. Ud. at 3-4.) Ifa method is used, however, Tucson suggests that it should be FIFO. Ud. at 19.) Under FIFO, “stocks acquired first are assumed to have been sold first in the calculation of losses.” Bo Young Cha, 2012 WL 2025850, at *3. PwC does not dispute that Tucson has recoverable damages under FIFO; likewise, Tucson does not dispute that it has no recoverable damages under LIFO. (Def.’s Moving Br. 4; Pls.’ Opp’n Br. 2.) B. The Special Master’s Report and Recommendation In recommending denial of PwC’s Motion, the Special Master (1) rejected PwC’s argument that damages are an element of a Section 11 claim and (2) found it premature to employ any specific matching methodology at this procedural stage. (R&R *5, *10, ECF No. 563.) Regarding the matching methodologies, the Special Master noted that “[nJeither party at this point has provided testimony, expert or otherwise, to address the manner in which [Tucson] incurred stock

Free access — add to your briefcase to read the full text and ask questions with AI

POTTER v. VALEANT PHARMACEUTICALS INTERNATIONAL, INC., (D.N.J. 2021).

POTTER v. VALEANT PHARMACEUTICALS INTERNATIONAL, INC. (POTTER v. VALEANT PHARMACEUTICALS INTERNATIONAL, INC.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Herman & MacLean v. Huddleston
459 U.S. 375 (Supreme Court, 1983)
Dura Pharmaceuticals, Inc. v. Broudo
544 U.S. 336 (Supreme Court, 2005)
Justice Allah v. George Hayman
442 F. App'x 632 (Third Circuit, 2011)
Mcmahan & Company v. Wherehouse Entertainment, Inc.
65 F.3d 1044 (Second Circuit, 1995)
McCabe v. Ernst & Young, LLP
494 F.3d 418 (Third Circuit, 2007)
Rosenau v. Unifund Corp.
539 F.3d 218 (Third Circuit, 2008)
In Re Countrywide Financial Corporation Securities Litigation
588 F. Supp. 2d 1132 (C.D. California, 2008)
Syncsort Inc. v. Sequential Software, Inc.
50 F. Supp. 2d 318 (D. New Jersey, 1999)
In Re Mutual Funds Investment Litigation
384 F. Supp. 2d 845 (D. Maryland, 2005)
In Re Cigna Corp. Securities Litigation
459 F. Supp. 2d 338 (E.D. Pennsylvania, 2006)
In Re Royal Dutch/Shell Transport Securities Litigation
380 F. Supp. 2d 509 (D. New Jersey, 2005)
Metz v. United Counties Bancorp
61 F. Supp. 2d 364 (D. New Jersey, 1999)
In Re Initial Public Offering Securities Litigation
241 F. Supp. 2d 281 (S.D. New York, 2003)
Pelletier v. Endo Int'l PLC
316 F. Supp. 3d 846 (E.D. Pennsylvania, 2018)
In re eSpeed, Inc. Securities Litigation
232 F.R.D. 95 (S.D. New York, 2005)